Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Min Hou
Institution:
Affiliated Hospital of North Sichuan Medical College
Observed institution:
Affiliated Hospital of North Sichuan Medical College
ORCID:
0000-0003-0481-4418
Observed ORCID:
0000-0003-0481-4418
OpenAlex ID:
A5041167674
[Retracted] Linalool Impress Colorectal Cancer Deterioration by Mediating AKT/mTOR and JAK2/STAT3 Signaling Pathways
2022
·
Min Hou
, Yakun Zhang
, et al.
·
BioMed Research International
·
10
PDF
Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study
2026
·
Jingyuan Wen
, Xinyi Liu
, et al.
·
Cancer Immunology Immunotherapy
·
1
PDF
Optimal Sequencing of First‐Line Immune Checkpoint Inhibitors With Definitive Chemoradiotherapy: A Multicenter Real‐World Cohort Study Comparing Induction, Concurrent, and Consolidation Strategies for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
2026
·
Xiaohan Zhao
, Shiwang Wen
, et al.
·
International Journal of Cancer
PDF
Cadonilimab combined with anlotinib in patients with advanced NSCLC refractory to prior systemic therapy and anti–PD-(L)1 antibodies: A phase II study.
2026
·
Juncai Ye
, Min Hou
, et al.
·
Journal of Clinical Oncology
The FGD5-AS1/miR-142-5p/CDK5 axis promotes ESCC progression by regulating mitochondrial fission and mitophagy: insights from integrative bioinformatics and experimental analyses
2026
·
Min Hou
, Shan Chen
, et al.
·
World Journal of Surgical Oncology
PDF
RNA binding protein RBM22 suppresses non-small cell lung cancer tumorigenesis by stabilizing LATS1 mRNA
2024
·
Min Hou
, Qingmei Huang
, et al.
·
Journal of Molecular Histology
Show more works
View as search
Works count:
6
Citation count:
11
H-index:
1
I10-index:
1
Year
Topic
Type